These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31378555)

  • 1. Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.
    Alcover KC; Oluwoye O; Kriegel L; McPherson S; McDonell MG
    Schizophr Res; 2019 Sep; 211():86-87. PubMed ID: 31378555
    [No Abstract]   [Full Text] [Related]  

  • 2. RAISE-ing Our Expectations for First-Episode Psychosis.
    Insel TR
    Am J Psychiatry; 2016 Apr; 173(4):311-2. PubMed ID: 26481175
    [No Abstract]   [Full Text] [Related]  

  • 3. [A model of care for first-episode psychosis: the RAISE-ETP project].
    Azorin JM; Adida M; Belzeaux R; Fakra E
    Encephale; 2016 Jun; 42 Suppl 3():S13-S17. PubMed ID: 27769347
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.
    Kane JM; Robinson DG; Schooler NR; Mueser KT; Penn DL; Rosenheck RA; Addington J; Brunette MF; Correll CU; Estroff SE; Marcy P; Robinson J; Meyer-Kalos PS; Gottlieb JD; Glynn SM; Lynde DW; Pipes R; Kurian BT; Miller AL; Azrin ST; Goldstein AB; Severe JB; Lin H; Sint KJ; John M; Heinssen RK
    Am J Psychiatry; 2016 Apr; 173(4):362-72. PubMed ID: 26481174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Setién-Suero E; Martínez-García O; de la Foz VO; Vázquez-Bourgon J; Correa-Ghisays P; Ferro A; Crespo-Facorro B; Ayesa-Arriola R
    Schizophr Res; 2018 Nov; 201():159-166. PubMed ID: 29861266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the level of exposure to stress factors and cannabis in recent onset psychosis.
    Arranz S; Monferrer N; Jose Algora M; Cabezas A; Sole M; Vilella E; Labad J; Sanchez-Gistau V
    Schizophr Res; 2018 Nov; 201():352-359. PubMed ID: 29743139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder.
    Garel N; Greenway K; Joober R
    J Psychiatry Neurosci; 2021 Jan; 46(1):E164-E165. PubMed ID: 33464779
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study.
    Mueser KT; Meyer-Kalos PS; Glynn SM; Lynde DW; Robinson DG; Gingerich S; Penn DL; Cather C; Gottlieb JD; Marcy P; Wiseman JL; Potretzke S; Brunette MF; Schooler NR; Addington J; Rosenheck RA; Estroff SE; Kane JM
    Schizophr Res; 2019 Feb; 204():271-281. PubMed ID: 30139553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazary J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):212-7. PubMed ID: 21087649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasons for cannabis use in psychosis.
    Schofield D; Tennant C; Nash L; Degenhardt L; Cornish A; Hobbs C; Brennan G
    Aust N Z J Psychiatry; 2006; 40(6-7):570-4. PubMed ID: 16756582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Kelley ME; Wan CR; Broussard B; Crisafio A; Cristofaro S; Johnson S; Reed TA; Amar P; Kaslow NJ; Walker EF; Compton MT
    Schizophr Res; 2016 Mar; 171(1-3):62-7. PubMed ID: 26785806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: Data from the national RAISE-ETP study.
    Oluwoye O; Monroe-DeVita M; Burduli E; Chwastiak L; McPherson S; McClellan JM; McDonell MG
    Early Interv Psychiatry; 2019 Feb; 13(1):142-146. PubMed ID: 29356438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Br J Psychiatry; 2014 Jun; 204(6):448-53. PubMed ID: 24578446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
    J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
    Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
    Malcolm CP; Picchioni MM; DiForti M; Sugranyes G; Cooke E; Joseph C; McQueen G; Paparelli A; Stilo S; O'Connor J; Morgan C; Murray RM; Hodgins S
    Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.